Almaden Genomics
David Gascoigne is the Chief Executive Officer at Almaden Genomics, where David leads the development of the g.nome™ platform. David has previously held leadership roles in companies like Sutherland, Gene Network Sciences, IQVIA, Symphony Health, Accenture, IMS Health, and Millward Brown, specializing in healthcare analytics, commercial analytics, marketing analytics, and statistical analysis.
This person is not in any teams
This person is not in any offices
Almaden Genomics
Almaden Genomics is accelerating genomic discovery with g.nome, a cloud-native platform designed to streamline genomic workflows. Brought to market by a team of bioinformaticians, engineers and industry professionals, Almaden’s g.nome platform allows for a low-code/no-code pipeline build. With a visual drag-and-drop pipeline builder that utilizes toolkits and pre-built workflows from a curated library, g.nome is giving power to researchers — enabling them to import custom code, handle big datasets reliably and optimize team collaboration from anywhere. With g.nome, research teams can do what they do best: focus on the science.